Evidence map›Paper›PMID 41821912›Full record

ArticleCentral European journal of urology2026

Retrospective analysis to evaluate Allium stents as an alternative method for the treatment of ureteral strictures.

Krzysztof Nowakowski, Agata Panfil, Agata Lurka, Piotr Matuszak, Grzegorz Prokopowicz, Andrzej Potyka

Abstract read
In one paragraph

Article in Central European journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Krzysztof NowakowskiDepartment of Urology and Urological Oncology, Academy of Silesia, Faculty of Medicine, Katowice, Poland.
Agata PanfilAcademy of Silesia, Faculty of Medicine, Katowice, Poland.
Agata LurkaAcademy of Silesia, Faculty of Medicine, Katowice, Poland.
Piotr MatuszakAcademy of Silesia, Faculty of Medicine, Katowice, Poland.
Grzegorz ProkopowiczDepartment of Urology and Urological Oncology, Regional Specialist Hospital No. 3, Rybnik, Poland.
Andrzej PotykaDepartment of Urology and Urological Oncology, Academy of Silesia, Faculty of Medicine, Katowice, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Allium metal ureteral stents have become an increasingly popular endoscopic treatment option for ureteral strictures. This study aimed to present the outcomes of Allium ureteral stents in the treatment of refractory ureteral strictures of different origin at a single center. Material and methods: The objective of our study is to present the retrospective analysis of patients treated with an Allium ureteral stent in our department and to evaluate its effectiveness. The success rate of treatment, postoperative resolution in hydronephrosis, symptom and complication rates were evaluated during the follow-up period. The study group consisted of 18 patients with unilateral or bilateral hydronephrosis due to the ureteral stricture of different etiologies. Results: The total percentage of regression of hydronephrosis was observed in 77.78% of cases. The median follow-up period was 575 days. The main causes of hydronephrosis were urolithiasis and its previous treatment, as well as neoplastic diseases of the abdomen and pelvis. Conclusions: The study found that the use of Allium ureteral stents can be an effective and helpful option in the treatment of ureteral strictures, especially in cases where primary treatment options are not suitable.

Indexed as

hydronephrosisureteral stentureteral stricture

Identifiers

PMID41821912
PMCPMC12976751

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.